Ibrahim AlZaim

572 total citations
24 papers, 402 citations indexed

About

Ibrahim AlZaim is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Physiology. According to data from OpenAlex, Ibrahim AlZaim has authored 24 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 11 papers in Epidemiology and 11 papers in Physiology. Recurrent topics in Ibrahim AlZaim's work include Cardiovascular Disease and Adiposity (13 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Adipose Tissue and Metabolism (8 papers). Ibrahim AlZaim is often cited by papers focused on Cardiovascular Disease and Adiposity (13 papers), Adipokines, Inflammation, and Metabolic Diseases (9 papers) and Adipose Tissue and Metabolism (8 papers). Ibrahim AlZaim collaborates with scholars based in Lebanon, Egypt and Qatar. Ibrahim AlZaim's co-authors include Ahmed F. El‐Yazbi, Ali H. Eid, Yusra Al-Dhaheri, Joanna Kalucka, Marwan El‐Sabban, Laura de Rooij, Bilal N. Sheikh, Khaled S. Abd‐Elrahman, Omar Obeid and Assaad A. Eid and has published in prestigious journals such as Circulation, Nature Communications and The FASEB Journal.

In The Last Decade

Ibrahim AlZaim

23 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ibrahim AlZaim Lebanon 13 123 123 114 96 55 24 402
Changan Yu China 14 106 0.9× 71 0.6× 118 1.0× 137 1.4× 51 0.9× 32 487
Kiyoto Nishi Japan 10 72 0.6× 124 1.0× 157 1.4× 165 1.7× 29 0.5× 30 424
Shuo Pan China 12 78 0.6× 54 0.4× 110 1.0× 121 1.3× 72 1.3× 26 376
Hajnalka Lőrincz Hungary 11 85 0.7× 84 0.7× 74 0.6× 78 0.8× 59 1.1× 53 351
Júlio C Fraulob-Aquino Canada 9 142 1.2× 185 1.5× 125 1.1× 122 1.3× 119 2.2× 12 544
Qiu Gen Zhou China 9 100 0.8× 120 1.0× 59 0.5× 106 1.1× 58 1.1× 10 441
Atsuko Tomizawa Japan 8 178 1.4× 107 0.9× 75 0.7× 173 1.8× 43 0.8× 9 430
Hengdao Liu China 12 72 0.6× 51 0.4× 62 0.5× 183 1.9× 49 0.9× 26 399
Teresa Navarra Italy 11 73 0.6× 66 0.5× 61 0.5× 92 1.0× 56 1.0× 15 391
Stefano Capobianco Italy 5 68 0.6× 127 1.0× 166 1.5× 73 0.8× 42 0.8× 7 454

Countries citing papers authored by Ibrahim AlZaim

Since Specialization
Citations

This map shows the geographic impact of Ibrahim AlZaim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim AlZaim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim AlZaim more than expected).

Fields of papers citing papers by Ibrahim AlZaim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim AlZaim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim AlZaim. The network helps show where Ibrahim AlZaim may publish in the future.

Co-authorship network of co-authors of Ibrahim AlZaim

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim AlZaim. A scholar is included among the top collaborators of Ibrahim AlZaim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim AlZaim. Ibrahim AlZaim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasan, Sana S., David John, Martina Rudnicki, et al.. (2025). Obesity drives depot-specific vascular remodeling in male white adipose tissue. Nature Communications. 16(1). 5392–5392. 1 indexed citations
2.
Elwali, Nasr Eldin, et al.. (2024). Targeting GSK ‐3β for adipose dysfunction and cardiovascular complications of metabolic disease: An entangled WNT /β‐catenin question. The FASEB Journal. 38(24). e70273–e70273. 4 indexed citations
3.
AlZaim, Ibrahim, et al.. (2023). The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity. Nature Reviews Endocrinology. 19(12). 691–707. 45 indexed citations
4.
AlZaim, Ibrahim, et al.. (2023). Adipose tissue endothelial cells: insights into their heterogeneity and functional diversity. Current Opinion in Genetics & Development. 81. 102055–102055. 8 indexed citations
5.
AlZaim, Ibrahim, et al.. (2023). Periprostatic adipose tissue thromboinflammation triggers prostatic neoplasia in early metabolic impairment: Interruption by rivaroxaban. Life Sciences. 334. 122225–122225. 3 indexed citations
6.
AlZaim, Ibrahim, Ali H. Eid, Khaled S. Abd‐Elrahman, & Ahmed F. El‐Yazbi. (2022). Adipose tissue mitochondrial dysfunction and cardiometabolic diseases: On the search for novel molecular targets. Biochemical Pharmacology. 206. 115337–115337. 8 indexed citations
7.
8.
9.
AlZaim, Ibrahim, et al.. (2022). Depot-specific adipose tissue modulation by SGLT2 inhibitors and GLP1 agonists mediates their cardioprotective effects in metabolic disease. Clinical Science. 136(22). 1631–1651. 5 indexed citations
10.
Kellen, Eliane, et al.. (2021). Knowledge and Beliefs of Cancer Risk Factors and Early Cancer Symptoms in Lebanon: A Cross-sectional Survey Among Adults in the Community. Cancer Control. 28. 2895471197–2895471197. 7 indexed citations
11.
AlZaim, Ibrahim, et al.. (2021). Peri-renal adipose inflammation contributes to renal dysfunction in a non-obese prediabetic rat model: Role of anti-diabetic drugs. Biochemical Pharmacology. 186. 114491–114491. 30 indexed citations
12.
AlZaim, Ibrahim, Cynthia Tannous, A. A. B. HAZZAA, et al.. (2021). Transforming iodoquinol into broad spectrum anti-tumor leads: Repurposing to modulate redox homeostasis. Bioorganic Chemistry. 113. 105035–105035. 14 indexed citations
13.
AlZaim, Ibrahim, et al.. (2021). Perirenal Adipose Tissue Inflammation: Novel Insights Linking Metabolic Dysfunction to Renal Diseases. Frontiers in Endocrinology. 12. 707126–707126. 58 indexed citations
14.
AlZaim, Ibrahim, et al.. (2021). Sex Differences in Cardiovascular Impact of Early Metabolic Impairment: Interplay between Dysbiosis and Adipose Inflammation. Molecular Pharmacology. 102(1). 60–79. 2 indexed citations
15.
AlZaim, Ibrahim, et al.. (2021). Modulatory Effect of Intermittent Fasting on Adipose Tissue Inflammation: Amelioration of Cardiovascular Dysfunction in Early Metabolic Impairment. Frontiers in Pharmacology. 12. 626313–626313. 23 indexed citations
16.
AlZaim, Ibrahim, et al.. (2021). Phosphorus Supplementation Mitigates Perivascular Adipose Inflammation–Induced Cardiovascular Consequences in Early Metabolic Impairment. Journal of the American Heart Association. 10(24). e023227–e023227. 13 indexed citations
17.
18.
19.
AlZaim, Ibrahim, et al.. (2020). Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases. Frontiers in Cardiovascular Medicine. 7. 602088–602088. 55 indexed citations
20.
Elzahhar, Perihan A., et al.. (2020). The Emerging Role of COX-2, 15-LOX and PPARγ in Metabolic Diseases and Cancer: An Introduction to Novel Multi-target Directed Ligands (MTDLs). Current Medicinal Chemistry. 28(11). 2260–2300. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changan Yu Breakdown of academic impact, for papers by Kiyoto Nishi Breakdown of academic impact, for papers by Shuo Pan Breakdown of academic impact, for papers by Hajnalka Lőrincz Breakdown of academic impact, for papers by Júlio C Fraulob-Aquino Breakdown of academic impact, for papers by Qiu Gen Zhou Breakdown of academic impact, for papers by Atsuko Tomizawa Breakdown of academic impact, for papers by Hengdao Liu Breakdown of academic impact, for papers by Teresa Navarra Breakdown of academic impact, for papers by Stefano Capobianco
Rankless by CCL
2026